Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-023-01426-0
Published Online: 2023-06-23
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boye, Kristina S.
Stewart, Katie D.
Matza, Louis S. http://orcid.org/0000-0001-6374-5948
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2023-06-23
Version of Record valid from 2023-06-23
Article History
Received: 8 March 2023
Accepted: 15 May 2023
First Online: 23 June 2023